公开(公告)号：US20240262828A1

公开(公告)日：2024-08-08

申请号：US18543151

申请日：2023-12-18

申请人： Enanta Pharmaceuticals, Inc.

发明人： Joseph D. PANARESE ,  Dexter DAVIS ,  Samuel BARTLETT ,  Katherine CHONG ,  Nathaniel Thomas KENTON ,  Yat Sun OR

IPC分类号： C07D471/14 ,  A61K45/06

CPC分类号： C07D471/14 ,  A61K45/06

摘要： The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof:




which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.